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Abstract: Microcystins (MCs) are the most frequently found cyanobacterial toxins in 
freshwater systems. Many MC variants have been identified and variants differ in their 
toxicity. Recent studies showed that the variants MC-LW and MC-LF might be more toxic 
than MC-LR, the variant that is most abundant and mostly used for risk assessments. As 
little is known about the presence of these two variants in The Netherlands, we determined 
their occurrence by analyzing 88 water samples and 10 scum samples for eight MC 
variants ((dm-7-)MC-RR, MC-YR, (dm-7-)MC-LR, MC-LY, MC-LW and MC-LF) by 
liquid chromatography with tandem mass spectrometry detection. All analyzed MC 
variants were detected, and MC-LW and/or MC-LF were present in 32% of the MC 
containing water samples. When MC-LW and MC-LF were present, they contributed to 
nearly 10% of the total MC concentrations, but due to their suspected high toxicity, their 
average contribution to the total MC toxicity was estimated to be at least 45%. Given the 
frequent occurrence and possible high toxicity of MC-LW and MC-LF, it seems better to 
base health risk assessments on the toxicity contributions of different MC variants than on 
MC-LR concentrations alone. 
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1. Introduction 
The incidence and intensity of cyanobacterial blooms are on the rise worldwide [1,2]. 
Cyanobacterial blooms present a serious health threat because cyanobacteria might produce potent 
toxins [3] of which microcystins (MCs) are most frequently encountered in freshwater blooms all 
around the world [4]. MCs are non-ribosomally synthesized cyclic heptapeptides with a size between 
909 and 1115 Da [4,5]. Their general structure is cyclo(-D-ala-L-X-erythro-β-D-methylaspartic  
acid-L-Y-Adda-D-isoglutamic acid-N-methyldehydroalanine), where Adda is (2S,3S,8S,9S)-3-amino-9-
methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid and X and Y are variable L-amino acids [6] 
(Figure 1). 
Figure 1. General structure of microcystins and examples of substitutions at position X and 
Y resulting in the variants MC-RR, MC-LR, MC-LW and MC-LF if positions R1 and R2 
are methylated. 
 
MCs are potent inhibitors of protein phosphatases and they primary cause liver damage, although 
other organs can also be affected [7]. Furthermore, MCs are tumor promoters [7,8]. The toxicity of 
different variants when administered by intraperitoneal injection (i.p.) to mice varies substantially. 
MC-LR is the most toxic variant and replacement of the hydrophobic leucine (L) in position X with a 
more hydrophilic amino acid (e.g., arginine, R) reduces toxicity [8]. No mouse toxicity data are 
available for MC-LW and MC-LF, but recent in vitro studies show that these variants, in which the 
hydrophobic amino acids tryptophan (W) or phenylalanine (F) occupy position Y, were distinctly more 
toxic than MC-LR. They were more cytotoxic than MC-LR to human hepatocytes, organic anion 
transporting polypeptide (OATP)-transfected embryonic kidney cells and Caco-2 cells [9,10] and also 
to primary murine whole brain cells [11]. Also when other endpoints were used, like tau 
phosphorylation and neurite length of murine neurons [12], proliferation and morphology of human 
Caco-2 cells [10] and growth inhibition in human OATP-transfected HeLa cells [13], MC-LW and 
MC-LF were distinctly more toxic than MC-LR. Because MC-LW and MC-LF were approximately 
equally strong protein phosphatase inhibitors as MC-LR [9,10,13], their enhanced toxicity can 
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probably be attributed to the greater ability of these variants to enter cells, either because of variant 
dependent OATP mediated transport [14] or because of differences in the interaction with  
membranes [15]. MC-LW and MC-LF were also more toxic to the protozoan Tetrahymena pyriformis 
than MC-LR [16], although this effect was less pronounced than in the in vitro studies (Table 1). 
Table 1. Relative toxicity of seven microcystin variants to MC-LR based on different 
endpoints, higher numbers indicate higher toxicity. i.p.: Intraperitoneal injection; dm-7: 
demethylated at position R2; n.d.: Not determined. 
MC variant LD50 mouse (i.p.) [8] LC50 protozoan [16] EC50 in vitro 
1
 [9] Factor used in this study 
dm-7-MC-RR 0.28 n.d. n.d. 0.28 
MC-RR 0.06–0.10 n.d. 0.02–0.20 0.08 
MC-YR 0.25–0.33 n.d. n.d. 0.29 
dm-7-MC-LR 0.20 n.d. n.d. 0.20 
MC-LY 0.56 1.1–1.4 n.d. 0.56 
MC-LW n.d. 1.9–2.9 7–64 7 
MC-LF n.d. 2.0–3.0 7–69 7 
1 Based on the cytotoxicity to human primary hepatocytes and OATP-transfected human embryonic kidney cells. 
Few reports exist on the occurrence of MC-LW and MC-LF in environmental samples. MC-LR is 
one of the most frequently observed MCs in the environment along with the variants MC-RR and  
MC-YR [4]. However, when looked for, MC-LW and MC-LF have also been detected [17–26], albeit 
not in all cases (e.g., [27–29]). Despite the potential higher toxicity of MC-LW and MC-LF, risk 
assessments are often based on MC-LR or MC-LR equivalents, and only sometimes on total MC or 
MC-LR toxicity equivalents [30]. 
In The Netherlands, MCs are the most abundant cyanotoxins, but little information exists on the 
occurrence of different variants, as most MC analyses have been performed by ELISA. Occasionally, 
some environmental samples have been analyzed by high-performance liquid chromatography with 
photodiode array detection but only for the variants MC-LR, MC-RR and MC-YR [31]. However, 
recently we showed that considerable amounts of the variants MC-LW and MC-LF were present in 
cyanobacterial material from a case of dog fatalities in The Netherlands [25]. The aim of the current 
research was therefore to determine the occurrence of MC-LW and MC-LF in Dutch surface waters 
and to estimate their contribution to the total MC toxicity. For this, 88 water samples and 10 scum 
samples from 86 sites in The Netherlands (Figure 2) were analyzed for eight MC-variants and 
nodularin by liquid chromatography with tandem mass spectrometry detection (LC-MS/MS). 
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Figure 2. Sampling sites in the Netherlands. 
 
2. Results and Discussion 
Microcystins were detected in 77 out of 88 water samples analyzed. In four samples MCs were 
present only at trace levels, but in 73 samples in sufficient amounts to allow quantification (Table 2). 
MC-LR was the most frequently encountered variant being present in 85% of the samples, followed by 
MC-YR (82%), dm-7-MC-LR (81%), MC-RR (78%) and dm-7-MC-RR (66%). MC-LY (28%),  
MC-LW (23%) and MC-LF (26%) were less frequently detected and mostly occurred together 
(Supplementary Table S1 and Table 2). Microcystis aeruginosa or M. flos-aquae were dominantly 
present in all but one location where MC-LW and MC-LF were detected. The other location where 
MC-LF was present was dominated by Woronichinia naegeliana and Anabaena flos-aquae 
(Supplementary Table S1). MC-LR, dm-7-MC-LR, MC-YR and MC-RR were also most frequently 
present in the cyanobacterial scums as they were detected in each sample. dm-7-MC-RR was detected 
in eight of the 10 samples and MC-LY, MC-LW and MC-LF were again less frequently detected, they 
were encountered in four of the 10 samples (Table 3). Also, in the scums, MC-LY, MC-LW and  
MC-LF were mostly detected together and they were detected at locations where either M. aeruginosa, 
W. naegeliana or A. flos-aquae was present (Supplementary Table S2). 
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Table 2. Microcystin (MC) concentrations (μg/L) detected in 88 water samples, 
summarized from Supplementary Table S1. Nodularin was not detected. 
 
dm-7-RR RR YR dm-7-LR LR LY LW LF Total MC 
average 0.45 5.0 2.4 4.0 35 5.9 14 4.2 49 
median 0.20 0.81 0.23 0.12 1.3 0.35 0.61 0.42 2.5 
maximum 3.6 66 41 220 2100 110 260 33 2800 
minimum 0.03 0.02 0.01 0.003 0.01 0.001 0.05 0.05 0.02 
n quantified 38 67 67 62 73 25 20 17 73 
n not quantified 20 2 5 9 2 0 0 6 4 
n not detected 30 19 16 17 13 63 68 65 11 
Table 3. Microcystin (MC) concentrations (μg/L) detected in 10 scum samples, 
summarized from Supplementary Table S2. Nodularin was not detected. 
 
dm-7-RR RR YR dm-7-LR LR LY LW LF Total MC 
average 47 780 230 41 1700 840 300 580 3400 
median 11 85 81 7.6 160 530 100 260 480 
maximum 170 4600 1200 230 7900 2300 990 1800 14,000 
minimum 4.3 3.8 1.2 0.89 3.0 24 10 8.0 26 
n detected 8 10 10 10 10 4 4 4 10 
n not detected 2 0 0 0 0 6 6 6 0 
These results confirm that MC-LR, MC-RR and MC-YR are in general more abundant than  
MC-LY, MC-LW and MC-LF (e.g., [18,20,26]). In our study, MC-LW and/or MC-LF were detected 
in 25 of the 77 water samples that contained MCs, which means they were present in 32% of the  
MC-containing samples. This is considerably more than the limited presence of MC-LF and MC-LW 
found in some studies [20,26], but less than the 45% found in lakes and reservoirs in the  
United States [18] and the 89% found in a Turkish lake [23]. Also in the American lakes, MC-LY, 
MC-LW and MC-LF mostly co-occurred, but this was not the case in the Turkish study.  
The maximum concentration of total MCs in the water samples was 2800 μg/L, and in two scum 
samples concentrations above 13,000 μg/L were detected (Tables 2 and 3). MC-LR was on average 
present in the highest concentrations in the water samples, dm-7-MC-RR had on average the lowest 
concentrations (Table 2, Figure 3). In water samples where MC-LW and MC-LF were present,  
MC-LW contributed on average 5.2% to the total MC concentration and MC-LF contributed  
4.6%. This is slightly higher than the values found in other field samples [17,18]. However, higher 
relative MC-LW and MC-LF concentrations have been reported from M. aeruginosa culture strains, 
e.g., 21% LW and 19% LF in PCC7820 [32] and 19% LW and 14% LF in AB2005/45 [33]. Those 
values match with the highest contributions found in our field survey; in the location  
Borne—t’Dijkhuis, MC-LW contributed for 14% to the total MC-pool, while a 14% contribution of 
MC-LF was found at Huizen—Gooihoofd (Supplementary Table S1). Thus, the MC variants MC-LW 
and MC-LF can make up a significant part of the total MC-pool. In one study, extracellular MC-LW 
was even present at a concentration of 99 μg/L, thereby making up 96% of the total dissolved MC pool 
in that sample [23].  
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Figure 3. Concentrations of eight different microcystin (MC) variants (μg/L) in 88 water 
samples from different sites in The Netherlands. Only values above quantification limit are 
included. Boundaries of the boxes indicate the 25th and 75th percentiles, lines within boxes 
mark the median, whiskers indicate the 10th and 90th percentiles, dots represent the 5th 
and 95th percentiles. 
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The contribution of each variant to the overall MC toxicity of a sample was determined by 
assigning a toxicity factor to each variant (Table 1) and by multiplying variant concentrations by these 
toxicity factors. Toxicity factors for dm-7-MC-RR, MC-RR, MC-YR, dm-7-MC-LR and MC-LY were 
estimated from the average i.p. LD50 values to mice as given in Zurawell et al. (2005) [8]. For MC-LW 
and MC-LF, the lowest reported in vitro toxicity factor to primary human hepatocytes was used [9]. 
The estimated toxicity contribution of MC-LW and MC-LF in the 21 samples, where these variants 
were detected above the quantification level, are shown in Figure 4. MC-LW and MC-LF significantly 
contribute to the overall MC toxicity when they are present; on average 45% of the total MC toxicity is 
caused by these two variants. It should be noted that these toxicity contributions are estimates and 
should therefore be interpreted with caution. For six variants, in vivo toxicity factors are used, while 
the contribution of MC-LW and MC-LF was estimated by in vitro toxicity factors. It is however 
unknown whether higher in vitro toxicity also results in higher in vivo toxicity, as little is known about 
the toxicokinetics and therefore the bioavailability of the latter variants. It is for instance not known 
whether MC-LW and MC-LF are stable in the stomach [15]. However, for other variants (MC-RR and 
MC-LR), comparison of in vivo and in vitro toxicity data resulted in comparable toxicity  
factors ([9], Table 1). Also, MC-LW and MC-LF were more toxic than MC-LR to the protozoan 
Tetrahymena pyriformis [16], so it is likely that the enhanced toxicity of MC-LW and MC-LF that was 
observed in vitro will also result in a higher toxicity in vivo. 
The total toxicity of the samples has only been based on the contribution of the eight MC variants 
that have been analyzed in this study. As dozens of MC variants have been reported [8] and individual 
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cyanobacterial strains can produce many variants (e.g., [33]), the total toxicity of the samples is likely 
underestimated. Furthermore, we cannot exclude the possibility that structural isomers, which 
sometimes exhibit different toxicities [8], have attributed to the signal of some of the eight MC 
variants analyzed in this study. Nevertheless, our analysis shows that MC-LW and MC-LF are likely to 
significantly contribute to the total MC toxicity when they are present. 
Figure 4. Estimated contribution of MC-LW and MC-LF to the total microcystin (MC) 
toxicity in 21 surface water samples with cyanobacterial presence. 
 
As it has become clear that MC-LW and MC-LF are regularly present in MC containing blooms 
and that their contribution to the total MC toxicity of these blooms can be substantial, it seems that risk 
assessment can better be based on the toxicity contributions of all MC variants than only on 
concentrations of MC-LR, as the first would be a better reflection of the health risk. To assess this risk, 
concentrations of individual MC variants should be analyzed. However, analytical methods that can 
identify different variants, such as LC-MS/MS operated in multiple reaction monitoring mode, have 
the disadvantage of potentially missing variants. Complementary to these methods, total MC 
concentrations could therefore be determined, for instance by Adda-based ELISA. In this way it can be 
checked whether the most abundant variants have indeed been identified. For The Netherlands, this 
would mean that the frequent use of ELISA for determination of MC concentrations should be 
complemented by analytical methods that can distinguish individual variants. 
3. Experimental Section  
3.1. Sample Origin 
Samples were collected from 86 fresh surface waters in The Netherlands from 2009 to 2012. All 
samples were taken in the months July, August, September and October. Locations differed in their 
morphology from small urban ponds to bigger lakes and sheltered beaches at river banks. Water 
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samples were collected in a polyethylene bottle, scum samples were collected in a small plastic cup. 
All samples were processed within 24 h of collection. 
3.2. Sample Extraction 
Cyanobacterial species in the samples were identified by light microscopy. Of the water samples, 
50 to 250 mL was glass-fiber filtered (GF/C, Whatman International Ltd., Maidstone, UK) and stored 
at −20 C. Of each scum sample, 1 mL was filtered over a GF/C filter and also these filters were stored 
at −20 C. Before extraction, filters were transferred to 8 mL glass tubes and placed for two hours in a  
freeze-drier (Alpha 1-2 LD, Martin Christ Gefriertrocknungsanlagen GmbH, Osterode am Harz, 
Germany). Subsequently, MCs were extracted three times at 60 C in 2.5 mL 75% methanol–25% 
Millipore water (v/v). Extracts were dried in a Speedvac (Savant SPD121P, Thermo Scientific, 
Waltham, MA, USA) and reconstituted in 900 μL methanol. The reconstituted samples were 
transferred to 2 mL Eppendorf vials with a cellulose-acetate filter (0.2 μm, Grace Davison Discovery 
Sciences, Deerfield, IL, USA) and centrifuged for 5 min at 16,000× g (Galaxy 16DH, VWR, 
International, Buffalo Grove, IL, USA). Filtrates were transferred to amber glass vials for  
LC-MS/MS analysis. If needed, samples with high MC concentrations were diluted in methanol  
before re-analysis. 
3.3. LC-MS/MS Analysis 
Samples were analyzed for eight MC variants (dm-7-MC-RR, MC-RR, MC-YR, dm-7-MC-LR, 
MC-LR, MC-LY, MC-LW and MC-LF) and nodularin (NOD) by LC-MS/MS as described in [25]. 
LC-MS/MS analysis was performed on an Agilent 1200 LC and an Agilent 6410A QQQ. The 
compounds were separated on an Agilent Eclipse XDB-C18 4.6 × 150 mm, 5 μm column by Millipore 
water with 0.1% formic acid (v/v, eluent A) and acetonitrile with 0.1% formic acid (v/v, eluent B). 
Elution program was 0–2 min 30% B, 6–12 min 90% B, with a linear increase of B between 2 and  
6 min and a 5 min post run at 30% B. Injection volume was 10 μL, flow 0.5 mL/min, column 
temperature was 40 C. The LC-MS/MS was operated in positive mode with an electrospray ionisation 
source, nitrogen was used as drying and collision gas. For each compound, two transitions were 
monitored in MRM mode. The first quadrupole was operated in unit mode, the second quadrupole was 
operated in widest mode. Dwell time was 50 ms. MS/MS settings for each compound are shown in 
Table 4. Calibration standards were obtained from DHI LAB Products (Hørsholm, Denmark) and 
prepared in methanol, samples were quantified against a calibration curve and subsequently corrected 
for recovery. Each sample was injected once. 
Information on recovery, repeatability, limit of detection and limit of quantification of the analysis 
is given in [25]. Chromatograms of a calibration standard and a sample are shown in Figure S1. 
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Table 4. MS/MS settings for microcystin (MC) and nodularin (NOD) analysis. 
Compound 
Retention 
time 
Precursor 
ion 
Fragmentor 
Quantifier 
ion 
CE 
1
 
quantifier 
Qualifier 
ion 
CE 
1
 
qualifier 
Ratio 
2
 
 
min m/z V m/z V m/z V % 
dm-7-MC-RR 6.93 512.8 135 135.1 26 70.1 85 1.2 
MC-RR 7.62 519.8 151 135.1 30 70.1 75 2.7 
NOD 8.03 825.5 220 135.1 70 70.1 95 44.2 
MC-YR 8.16 523.3 102 911.5 5 135.1 6 103.6 
dm-7-MC-LR 8.21 491.3 88 847.6 5 135.1 6 84.0 
MC-LR 8.24 498.3 88 135.1 6 482.3 6 56.7 
MC-LY 9.67 868.4 170 163.0 35 136.1 75 29.0 
MC-LW 10.22 891.5 146 163.0 31 159.0 75 26.9 
MC-LF 10.47 852.5 140 163.1 31 120.1 79 39.1 
1 Collision energy; 2 Ratio between abundance of the qualifier and quantifier ion. 
4. Conclusions  
The MC variants MC-LW and MC-LF were present in 32% of the MC-containing Dutch water 
samples. When present, these variants contributed on average to nearly 10% of the total MC 
concentration, but due to their suspected higher toxicity, their average contribution to overall MC 
toxicity of the samples was estimated to be at least 45%. Given this frequent occurrence and possible 
high toxicity, it seems better to base health risk estimations on the toxicity contributions of different 
MC variants than on MC-LR concentrations as is common practice in many countries [30]. 
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